UNSPSC 51373311: Aspirin/caffeine/dihydrocodeine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373311 Aspirin/caffeine/dihydrocodeine is a Commodity code that shows a significant mismatch between its nominal scope and recent state and local procurement activity. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026—solicits naloxone and safe drug deactivation systems, which bear no relationship to the code's pharmaceutical pain-relief and stimulant formulation. The county is seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, but this procurement falls outside the code's stated product category.

The code shows little relevant recent activity aligned with its aspirin/caffeine/dihydrocodeine product definition. Without additional opportunities that reflect the actual scope of the UNSPSC category—pain relievers, stimulants, or related pharmaceutical formulations—it is not possible to characterize active issuing-body interest, geographic spread, or market conditions under this code. State and local procurement activity under 51373311 does not appear in current solicitation records, and buyers seeking these pharmaceutical products may be tagging opportunities with mismatched codes or procuring through centralized cooperative purchasing vehicles not reflected in public postings.